Literature DB >> 20217235

alpha-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels.

Lubomir Prochazka1, Lan-Feng Dong, Karel Valis, Ruth Freeman, Stephen J Ralph, Jaroslav Turanek, Jiri Neuzil.   

Abstract

Mitocans are drugs selectively killing cancer cells by destabilizing mitochondria and many induce apoptosis via generation of reactive oxygen species (ROS). However, the molecular events by which ROS production leads to apoptosis has not been clearly defined. In this study with the mitocan alpha-tocopheryl succinate (alpha-TOS) the role of the Bcl-2 family proteins in the mechanism of malignant cell apoptosis has been determined. Exposure of several different cancer cell lines to alpha-TOS increased expression of the Noxa protein, but none of the other proteins of the Bcl-2 family, an event that was independent of the cellular p53 status. alpha-TOS caused a profound conformational change in the pro-apoptotic protein, Bak, involving oligomerization in all cell types, and this also applied to the Bax protein, but only in non-small cell lung cancer cells. Immunoprecipitation studies indicated that alpha-TOS activates the two BH1-3 proteins, Bak or Bax, to form high molecular weight complexes in the mitochondria. RNAi knockdown revealed that Noxa and Bak are required for alpha-TOS-induced apoptosis, and the role of Bak was confirmed using Bak- and/or Bax-deficient cells. We conclude that the major events induced by alpha-TOS in cancer cells downstream of ROS production leading to mitochondrial apoptosis involve the Noxa-Bak axis. It is proposed that this represents a common mechanism for mitochondrial destabilization activated by a variety of mitocans that induce accumulation of ROS in the early phases of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20217235     DOI: 10.1007/s10495-010-0482-z

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  13 in total

1.  Targeting mitochondria by α-tocopheryl succinate kills neuroblastoma cells irrespective of MycN oncogene expression.

Authors:  Björn Kruspig; Azadeh Nilchian; Ignacio Bejarano; Sten Orrenius; Boris Zhivotovsky; Vladimir Gogvadze
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

2.  Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II.

Authors:  Lan-Feng Dong; Victoria J A Jameson; David Tilly; Jiri Cerny; Elahe Mahdavian; Alvaro Marín-Hernández; Luz Hernández-Esquivel; Sara Rodríguez-Enríquez; Jan Stursa; Paul K Witting; Bela Stantic; Jakub Rohlena; Jaroslav Truksa; Katarina Kluckova; Jeffrey C Dyason; Miroslav Ledvina; Brian A Salvatore; Rafael Moreno-Sánchez; Mark J Coster; Stephen J Ralph; Robin A J Smith; Jiri Neuzil
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

3.  Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model.

Authors:  Ferro Nguyen; Ivan Alferiev; Peng Guan; David T Guerrero; Venkatadri Kolla; Ganesh S Moorthy; Michael Chorny; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2018-03-07       Impact factor: 12.531

Review 4.  Use of anti-cancer drugs, mitocans, to enhance the immune responses against tumors.

Authors:  T Hahn; M J Polanczyk; A Borodovsky; L V Ramanathapuram; E T Akporiaye; S J Ralph
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

Review 5.  Inhibitors of succinate: quinone reductase/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death.

Authors:  Stephen J Ralph; Rafael Moreno-Sánchez; Jiri Neuzil; Sara Rodríguez-Enríquez
Journal:  Pharm Res       Date:  2011-08-24       Impact factor: 4.200

6.  Vitamin E Derivative with Modified Side Chain Induced Apoptosis by Modulating the Cellular Lipids and Membrane Dynamics in MCF7 Cells.

Authors:  Seher Gok; Oleksandr Kuzmenko; Andrii Babinskyi; Feride Severcan
Journal:  Cell Biochem Biophys       Date:  2021-01-13       Impact factor: 2.194

7.  Mitochondrially targeted α-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing.

Authors:  Jakub Rohlena; Lan-Feng Dong; Katarina Kluckova; Renata Zobalova; Jacob Goodwin; David Tilly; Jan Stursa; Alena Pecinova; Anatoly Philimonenko; Pavel Hozak; Jaideep Banerjee; Miroslav Ledvina; Chandan K Sen; Josef Houstek; Mark J Coster; Jiri Neuzil
Journal:  Antioxid Redox Signal       Date:  2011-12-15       Impact factor: 8.401

8.  Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy.

Authors:  Jaromira Kovarova; Martina Bajzikova; Magdalena Vondrusova; Jan Stursa; Jacob Goodwin; Maria Nguyen; Renata Zobalova; Elham Alizadeh Pesdar; Jaroslav Truksa; Marco Tomasetti; Lan-Feng Dong; Jiri Neuzil
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

9.  Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin K3 and ascorbate to trigger cell death.

Authors:  Marco Tomasetti; Linda Nocchi; Jiri Neuzil; Jacob Goodwin; Maria Nguyen; Lanfeng Dong; Nicola Manzella; Sara Staffolani; Claudio Milanese; Beatrice Garrone; Renata Alleva; Battista Borghi; Lory Santarelli; Roberto Guerrieri
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

10.  Mitochondrial Pathway of α-Tocopheryl Succinate-Induced Apoptosis in Human Epidermoid Carcinoma A431 Cells.

Authors:  M A Savitskaya; M S Vildanova; O P Kisurina-Evgenieva; E A Smirnova; G E Onischenko
Journal:  Acta Naturae       Date:  2012-07       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.